QSAR development to describe HIV-1 integrase inhibition

被引:20
|
作者
Yuan, H [1 ]
Parrill, AL [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
来源
基金
美国国家科学基金会;
关键词
human immunodeficiency virus; integrase; quantitative structure-activity relationship; inhibition; multiple linear regression;
D O I
10.1016/S0166-1280(00)00553-4
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
HIV-1 integrase(IN) is one of three viral enzymes required for replication. IN mediates integration of viral DNA into the host genome in two steps: 3'-processing and strand transfer. It is currently recognized as an important target for therapeutic development against AIDS. QSAR (Quantitative Structure-Activity Relationship) modeling was utilized to study HIV-1 integrase inhibition. QSAR models were constructed to predict the IC50 values for the two structural classes (salicyhydrazines and tyrphostins) independently and in combination. The results showed that the models for different structural classes have different dependence on the same descriptors. It suggests that salicylhydrazines and tyrphostins might have different binding sites in HIV-1 integrase. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:273 / 282
页数:10
相关论文
共 50 条
  • [31] Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro
    Deprez, E
    Barbe, S
    Kolaski, M
    Leh, H
    Zouhiri, F
    Auclair, C
    Brochon, JC
    Le Bret, M
    Mouscadet, JF
    [J]. MOLECULAR PHARMACOLOGY, 2004, 65 (01) : 85 - 98
  • [32] Specific features of HIV-1 integrase inhibition by bisphosphonate derivatives
    Agapkina, Julia
    Yanvarev, Dmitry
    Anisenko, Andrey
    Korolev, Sergey
    Vepsalainen, Jouko
    Kochetkov, Sergey
    Gottikh, Marina
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 73 : 73 - 82
  • [33] Structural determinants for HIV-1 integrase inhibition by β-diketo acids
    Marchand, C
    Zhang, XC
    Pais, GCG
    Cowansage, K
    Neamati, N
    Burke, TR
    Pommier, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) : 12596 - 12603
  • [34] Allosteric Inhibitor Development Targeting HIV-1 Integrase
    Al-Mawsawi, Laith Q.
    Neamati, Nouri
    [J]. CHEMMEDCHEM, 2011, 6 (02) : 228 - 241
  • [35] Control of HIV through the inhibition of HIV-1 integrase: A medicinal chemistry perspective
    Gordon, C. P.
    Griffith, R.
    Keller, P. A.
    [J]. MEDICINAL CHEMISTRY, 2007, 3 (02) : 199 - 220
  • [36] Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors
    Han, Ying-Shan
    Xiao, Wei-Lie
    Quashie, Peter K.
    Mesplede, Thibault
    Xu, Hongtao
    Deprez, Eric
    Delelis, Olivier
    Pu, Jian-Xin
    Sun, Han-Dong
    Wainberg, Mark A.
    [J]. ANTIVIRAL RESEARCH, 2013, 98 (03) : 441 - 448
  • [37] Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts
    Ahn, MJ
    Yoon, KD
    Kim, CY
    Min, SY
    Kim, YU
    Kim, HJ
    Kim, JH
    Shin, CG
    Lee, CK
    Kim, TG
    Kim, SH
    Huh, H
    Kim, J
    [J]. JOURNAL OF APPLIED PHYCOLOGY, 2002, 14 (05) : 325 - 329
  • [38] Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts
    Mi-Jeong Ahn
    Kee-Dong Yoon
    Chul Young Kim
    So-Young Min
    Yong-ung Kim
    Hyun Jin Kim
    Jeong Ha Kim
    Cha-Gyun Shin
    Chong-Kyo Lee
    Tae Gyun Kim
    Seung Hee Kim
    Hoon Huh
    Jinwoong Kim
    [J]. Journal of Applied Phycology, 2002, 14 : 325 - 329
  • [39] HIV-1 integrase inhibitor
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (04) : 170 - 170
  • [40] QSAR Study on Diketo Acid and Carboxamide Derivatives as Potent HIV-1 Integrase Inhibitor
    Adebimpe, Arodola Olayide
    Dash, Radha Charan
    Soliman, Mahmoud E. S.
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (05) : 618 - 627